Explore more publications!
Maryland Healthcare Reporter
Got News to Share?

Maryland Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Maryland Healthcare Reporter.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on April 7, 2026

AI and Online Health Information Are Booming, But Americans Don’t Fully Trust What They Find
Apr. 7, 2026

AI and Online Health Information Are Booming, But Americans Don’t Fully Trust What They Find

Indeterminate GlobeNewswire
Outlook Therapeutics Announces Formal Dispute Resolution Request for ONS-5010/LYTENAVA™ (bevacizumab-vikg) Accepted by FDA
Apr. 7, 2026

Outlook Therapeutics Announces Formal Dispute Resolution Request for ONS-5010/LYTENAVA™ (bevacizumab-vikg) Accepted by FDA

Indeterminate GlobeNewswire
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners
Apr. 7, 2026

Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners

Indeterminate GlobeNewswire
Moleculin Releases Next CEO Corner Segment Highlighting Annamycin’s Non-Cardiotoxic Profile
Apr. 7, 2026

Moleculin Releases Next CEO Corner Segment Highlighting Annamycin’s Non-Cardiotoxic Profile

Indeterminate GlobeNewswire
20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform
Apr. 7, 2026

20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform

Indeterminate GlobeNewswire
Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting
Apr. 7, 2026

Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting

Indeterminate GlobeNewswire
Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors
Apr. 7, 2026

Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors

Indeterminate GlobeNewswire
Clover Health Empowers Members to Take Charge of Their Health Data Through HealthEx Partnership
Apr. 7, 2026

Clover Health Empowers Members to Take Charge of Their Health Data Through HealthEx Partnership

Indeterminate GlobeNewswire
Integra LifeSciences Unveils New Real-World Evidence Highlighting PriMatrix® Utilization
Apr. 7, 2026

Integra LifeSciences Unveils New Real-World Evidence Highlighting PriMatrix® Utilization

Indeterminate GlobeNewswire
SS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026
Apr. 7, 2026

SS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026

Indeterminate GlobeNewswire
CorMedix to Participate in Needham Virtual Healthcare Conference
Apr. 7, 2026

CorMedix to Participate in Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire
Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference
Apr. 7, 2026

Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire
CDT Notes Sarborg Publication of PRISM Framework Expanding AI
Apr. 7, 2026

CDT Notes Sarborg Publication of PRISM Framework Expanding AI

Indeterminate GlobeNewswire
BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform
Apr. 7, 2026

BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform

Indeterminate GlobeNewswire
NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer
Apr. 7, 2026

NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer

Indeterminate GlobeNewswire
Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness
Apr. 7, 2026

Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness

Indeterminate GlobeNewswire
Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01
Apr. 7, 2026

Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01

Indeterminate GlobeNewswire
Lyell Immunopharma Announces Participation in 25th Annual Needham Virtual Healthcare Conference
Apr. 7, 2026

Lyell Immunopharma Announces Participation in 25th Annual Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire
Inhibikase Therapeutics Announces Enrollment of First Patient in IMPROVE-PAH Global Phase 3 Study of IKT-001 in the Treatment of Pulmonary Arterial Hypertension
Apr. 7, 2026

Inhibikase Therapeutics Announces Enrollment of First Patient in IMPROVE-PAH Global Phase 3 Study of IKT-001 in the Treatment of Pulmonary Arterial Hypertension

Indeterminate GlobeNewswire
Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month
Apr. 7, 2026

Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions